Article Details

Taiwan, India ink pharma collaboration worth $217M

Retrieved on: 2021-03-05 17:15:00

Tags for this article:

Click the tags to see associated articles and topics

Taiwan, India ink pharma collaboration worth $217M. View article details on hiswai:

Excerpt

Intas' US affiliate, Accord BioPharma, Inc. will be commercializing the Camcevi® products in the US market. Intas, a global biopharmaceutical company, ...

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up